Alex Braun
Head of Investor Relations
Replay available
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chief Executive Officer
Chief Development Officer
CFO and Chief Business Officer
Chief Medical Officer
Analyst, Bank of America
Analyst, Citi
Analyst, Stifel
Watch the replay and follow the connected company analysis, news, and investor updates for Acumen Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.017 Good day and welcome to the Acumen Pharmaceuticals second quarter 2025 conference call 00:00:05.017 -- 00:00:09.282 and webcast. At this time, all participants are in listen-only mode. 00:00:09.282 -- 00:00:12.886 After the speaker's presentation, there will be a question and answer session. 00:00:12.886 -- 00:00:15.730 To ask a question at that time, please press star 1-1. 00:00:15.730 -- 00:00:20.856 As a reminder, this call may be recorded. I would like to turn the call over to 00:00:20.856 -- 00:00:24.821 Alex Braun, Head of Investor Relations. Please go ahead. 00:00:24.821 -- 00:00:28.890 Thanks, Michelle. Good morning, and welcome to the Acumen conference call to discuss 00:00:28.890 -- 00:00:33.697 our business update and financial results for the quarter ended June 30th, 2025. 00:00:33.697 -- 00:00:35.179 With 00:00:35.179 -- 00:00:38.783 me today are Dan O'Connell, our Chief Executive Officer, Dr. 00:00:38.783 -- 00:00:43.650 Jim Doherty, our Chief Development Officer, and Matt Buga, our CFO and Chief Business 00:00:43.650 -- 00:00:45.152 Officer. 00:00:45.152 -- 00:00:49.377 Dan and Matt have some prepared remarks, and then we'll open the call for questions. 00:00:49.377 -- 00:00:51.980 Joining for the Q&A session, we also have Dr. 00:00:51.980 -- 00:00:55.060 Eric Siemers, our Chief Medical Officer. 00:00:55.060 -- 00:00:58.766 Before we begin, we encourage listeners to go to the Investors section of the Acumen 00:00:58.766 -- 00:01:03.674 website to find our press release issued this morning that we'll discuss today. 00:01:03.674 -- 00:01:07.301 Please note that during today's conference call, we may make forward-looking statements 00:01:07.301 -- 00:01:11.187 within the meaning of the federal securities laws, including...